~~<i id='7737F3165C'><strike id='7737F3165C'><tt id='7737F3165C'><pre id='7737F3165C'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

focus

author：leisure time 2025-08-26 10:54:52 - browse：36152

the shape of a medical note connected by dots and lines — health tech coverage from STAT — Adobe

In recent months, the federal government has repeatedly told Medicare Advantage insurers that they cannot use artificial intelligence or algorithms to deny medical services the government routinely covers.

But in finalizing a rule to that effect, it also stepped into a thicket of questions from insurers about a technology that is especially difficult to pin down: What is AI? Can it be used at all to make decisions about the coverage of older patients? If so, how?

This week, the federal agency that oversees Medicare sought to boil it all down into a simple directive: Put the circumstances of the individual patient first, and your algorithm second.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Virginia high school admissions case could be legal follow

focus

explore

leisure time

entertainment

focus

Decisionsaboutwithdrawinglifesupportafteratraumaticbraininjuryareoftenmadewithin72hours.EMILYKASK/AF

WSS

Anesthesiologist group: stop taking Ozempic before surgery

Bird flu outbreak in cows is latest avian flu curveball

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Bird flu in milk supply is likely coming from asymptomatic cows

Cue Health's Covid

United colonoscopy coverage change 'may cost lives,' doctors say

knowledge

focus

focus

The cancer drug shortage isn’t new — and neither are the solutions

UnitedHealth financials solid despite Change Healthcare cyberattack

ChatGPT in medicine: STAT answers readers' burning questions

State Dept. review finds Biden bears some blame for Afghanistan failures

The cancer drug shortage isn’t new — and neither are the solutions

Cholera vaccine supply gets boost as demand surges globally

Anesthesiologist group: stop taking Ozempic before surgery

Heart attack and stroke risk calculators need revising

Virginia high school admissions case could be legal follow

Psychedelics group wrestles with new pharma identity

explore

BioMarin wins approval for gene therapy to treat hemophilia A

UnitedHealth financials solid despite Change Healthcare cyberattack

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

In Memoriam: Notable people who died in 2023

Exact Sciences stock tumbles despite strong cancer detection sales

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

leisure time

entertainment

focus

focus